Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.

about

KASL clinical practice guidelines: management of chronic hepatitis B Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.

P2860

Q26752475-10A3D864-1DEB-41B3-AB3A-F075399FD545 Q36954038-BA4FC33D-2F87-4C55-8087-FB3F651C44C9

P2860

Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.

Item

http://www.wikidata.org/entity/Q46267580

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Treatment of lamivudine-resist ...... lticenter retrospective study.

@en

Treatment of lamivudine-resist ...... lticenter retrospective study.

@nl

type

Item

label

Treatment of lamivudine-resist ...... lticenter retrospective study.

@en

Treatment of lamivudine-resist ...... lticenter retrospective study.

@nl

prefLabel

Treatment of lamivudine-resist ...... lticenter retrospective study.

@en

Treatment of lamivudine-resist ...... lticenter retrospective study.

@nl

P1476

Treatment of lamivudine-resist ...... lticenter retrospective study.

@en

P2093

Bo Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Eileen L Yoon

http://www.w3.org/2001/XMLSchema#string

Hong Soo Kim

http://www.w3.org/2001/XMLSchema#string

Hyung Joon Yim

http://www.w3.org/2001/XMLSchema#string

Hyung Soo Kim

http://www.w3.org/2001/XMLSchema#string

In Hee Kim

http://www.w3.org/2001/XMLSchema#string

Jeong Il Lee

http://www.w3.org/2001/XMLSchema#string

Ji Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Jin Woo Lee

http://www.w3.org/2001/XMLSchema#string

Joong Min Lee

http://www.w3.org/2001/XMLSchema#string

P2860

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir

Navigating the maze of hepatitis B treatments.

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.

P304

196-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365521.2012.722671

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23194375

http://www.w3.org/2001/XMLSchema#string

Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.

about

P2860

P2860

Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698